货号	规格	价格	上海	北京	武汉	南京
S80088-5mg	≥98%	￥593.00 S80088-5mg ￥593.00 现货	10 10	-	-	-
S80088-10mg	≥98%	￥904.00 S80088-10mg ￥904.00 现货	10 10	-	-	-
S80088-25mg	≥98%	￥1852.00 S80088-25mg ￥1852.00 现货	10 10	-	-	-
S80088-50mg	≥98%	￥2965.00 S80088-50mg ￥2965.00 现货	10 10	-	-	-
S80088-100mg	≥98%	￥4633.00 S80088-100mg ￥4633.00 现货	6 6	-	-	-
S80088-250mg	≥98%	￥9268.00 S80088-250mg ￥9268.00 现货	1 1	-	-	-

大包装询价收藏产品

加入购物车

产品介绍

CCT 137690 is a potent and orally available aurora kinase inhibitor with IC50s of 15, 25, and 19 nM for aurora A, B and C, respectively.

产品描述：

CCT 137690 is a potent and orally available aurora kinase inhibitor with IC50s of 15, 25, and 19 nM for aurora A, B and C, respectively.

靶点：

Aurora A:15 nM (IC50);Aurora B:25 nM (IC50);Aurora C:19 nM (IC50);Apoptosis;AuroraKinase;Autophagy

体内研究：

CCT 137690 slows the growth of the SW620 xenografts with no observed toxicity. CCT 137690 significantly inhibits tumour growth in a transgenic mouse model of neuroblastoma (TH-MYCN) that overexpresses MYCN protein and is predisposed to spontaneous neuroblastoma formation

参考文献：

1. Bavetsias V, et al. Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases: lead optimization studies toward the identification of an orally bioavailable preclinical development candidate. J Med Chem. 2010 Jul 22;53(14):5213-28. 2. Faisal A, et al. The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo. Mol Cancer Ther. 2011 Nov;10(11):2115-23.

溶解性：

Soluble in DMSO

保存条件：

-20℃

配置溶液浓度参考：

	1mg	5mg	10mg
1 mM	1.813 ml	9.067 ml	18.133 ml
5 mM	0.363 ml	1.813 ml	3.627 ml
10 mM	0.181 ml	0.907 ml	1.813 ml
50 mM	0.036 ml	0.181 ml	0.363 ml

注意：

部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。

参考文献

质检证书(COA)

输入产品批号：

如何获取质检证书(COA)?

请输入货号和一个与之匹配的批号。
例如:
批号：JS298415 货号：S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

质量

浓度

体积

分子摩尔量

计算重置